Jasper Therapeutics Stock (NASDAQ: JSPR) stock price, news, charts, stock research, profile.
You can purchase shares of Jasper Therapeutics (NASDAQ:JSPR) through any online brokerage.
Other companies in Jasper Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), Skye Bioscience (NASDAQ:SKYE), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM) and bluebird bio (NASDAQ:BLUE).
Jasper Therapeutics has a consensus price target of $47.49.
The stock price for Jasper Therapeutics (NASDAQ: JSPR) is $6.07 last updated January 22, 2025 at 7:32 PM EST.
There are no upcoming dividends for Jasper Therapeutics.
Jasper Therapeutics’s Q4 earnings are confirmed for Monday, March 3, 2025.
There is no upcoming split for Jasper Therapeutics.
Jasper Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.